A research team at the University of Wisconsin-Madison produced high-resolution images of RSV structure, important for RSV ...

The biotech company, which makes the Spikevax RNA-based Covid-19 vaccine, reported net income of $13 million, or 3 cents a share, compared with a loss of $3.6 billion, or $9.53 a share, in the same ...

Moderna (MRNA) stock gains as company posts better than expected Q3 results driven by its updated COVID-19 vaccine. Read more ...

Respiratory syncytial virus (RSV) is a negative-stranded, RNA-based respiratory paramyxovirus with ten genes encoding 11 proteins. Three proteins are present in the viral envelope, including the ...

Moderna Chief Human Resources Officer Tracey Franklin has expanded her role to Chief People and Digital Technology Officer, overseeing the Company's talent and digital functions. Brad Miller, Chief ...

While the CDC said this winter peak is likely to be higher than the summer's, hospitalizations are likely to be lower than last year.

Do you know a “master of metamorphosis”? A scholar, some time ago, thus defined the influenza virus. Because it changes.

EvolutionaryScale can design proteins with desired properties according to prompts by simultaneously evolving sequence, ...

Moderna Inc. said Thursday that it has entered into an agreement to buy the properties it currently leases in Norwood.

He said Pfizer has been taking steps for some time to cut costs and has made changes to its corporate structure ... a weak launch of its respiratory syncytial virus (RSV) vaccine, and pulling ...

Pfizer today announced that its respiratory syncytial virus (RSV) vaccine Abrysvo maintained high efficacy ... genes (ARGs), virulence-associated genes (VAGs), and population structure using ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...